K Number
K020854
Device Name
MODIFICATION TO FOX PTA CATHETER
Manufacturer
Date Cleared
2002-04-11

(27 days)

Product Code
Regulation Number
870.1250
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Fox PTA Catheter is intended for dilatation of lesions in the femoral, renal, iliac, popliteal, peroneal, and profunda arteries and native or synthetic arteriovenous dialysis fistulae.
Device Description
The JOSTENT® Fox PTA Catheter consists of a double lumen catheter with a balloon located at the distal tip. The catheter will be available with balloon diameters of 3.0 - 12.0 mm and balloon lengths of 20 - 80 mm. The catheter will be available in lengths of 75 and 135 cm. The catheter is compatible with 0.035" diameter guidewires.
More Information

Not Found

No
The device description and summary of performance studies focus on the physical characteristics and basic functionality of a balloon catheter, with no mention of AI or ML.

Yes
The device is described as a PTA (Percutaneous Transluminal Angioplasty) Catheter intended for the "dilatation of lesions" in various arteries and arteriovenous dialysis fistulae. This activity directly treats a medical condition (lesions, blockages) with the goal of restoring proper blood flow, thus making it a therapeutic device.

No

Explanation: The device description states its purpose is for "dilatation of lesions," which is a treatment, not a diagnostic function. There is no mention of image processing, AI, or analysis of medical data for diagnostic purposes.

No

The device description clearly outlines a physical catheter with a balloon, indicating it is a hardware medical device, not software-only.

Based on the provided information, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly states that the device is for the "dilatation of lesions in the femoral, renal, iliac, popliteal, peroneal, and profunda arteries and native or synthetic arteriovenous dialysis fistulae." This is a therapeutic procedure performed directly on the patient's body.
  • Device Description: The description details a catheter with a balloon, designed for physical intervention within blood vessels.
  • Lack of IVD Characteristics: There is no mention of the device being used to examine specimens (like blood, urine, or tissue) in vitro (outside the body) to provide information for diagnosis, monitoring, or screening.

IVD devices are used to perform tests on samples taken from the body to provide diagnostic information. This device is a therapeutic device used for a medical procedure.

N/A

Intended Use / Indications for Use

The Fox PTA Catheter is intended for dilatation of lesions in the femoral, renal, iliac, popliteal, peroneal, and profunda arteries and native or synthetic arteriovenous dialysis fistulae.

Product codes

74 LIT

Device Description

The JOSTENT® Fox PTA Catheter consists of a double lumen catheter with a balloon located at the distal tip. The catheter will be available with balloon diameters of 3.0 - 12.0 mm and balloon lengths of 20 - 80 mm. The catheter will be available in lengths of 75 and 135 cm. The catheter is compatible with 0.035" diameter guidewires.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

femoral, renal, iliac, popliteal, peroneal, and profunda arteries and native or synthetic arteriovenous dialysis fistulae.

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

Bench, biocompatibility, and design control activities demonstrate the safety and effectiveness of the Fox PTA Catheter.

Key Metrics

Not Found

Predicate Device(s)

K010838, K000101, K003972

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 870.1250 Percutaneous catheter.

(a)
Identification. A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.(b)
Classification. Class II (performance standards).

0

APR 1 1 2002

Sponsor:
JOMED

510(k) SUMMARY -- Fox PTA Catheter

Submitter Name:Jomed AG
Submitter Address:Ampthauptstrasse, Postfach
CH-8222 Beringen, Switzerland
Contact Person:Rudi Ott
Phone Number:+ 41 52 674 8505
Fax Number:+41 52 674 8540
Date Prepared:15 March 2002
Device Trade Name:Fox PTA Catheter
Device Common Name:Peripheral Transluminal Angioplasty Catheter
Classification Name:21 CFR 870.1250 Percutaneous Catheter
Predicate Devices:• Jomed Fox PTA Catheter, K010838
• Guidant VIATRAC PTA Catheter, K000101
• NuMED Ghost II PTA Catheter, K003972
Device Description:The JOSTENT® Fox PTA Catheter consists of a double
lumen catheter with a balloon located at the distal tip.
The catheter will be available with balloon diameters of
3.0 - 12.0 mm and balloon lengths of 20 - 80 mm. The
catheter will be available in lengths of 75 and 135 cm.
The catheter is compatible with 0.035" diameter
guidewires.
Intended Use:The Fox PTA Catheter is intended for dilatation of
lesions in the femoral, renal, iliac, popliteal, peroneal,
and profunda arteries and native or synthetic
arteriovenous dialysis fistulae.
Device TechnologicalThe Fox PTA Catheter is made of similar materials, is

1

.

| Characteristics and
Comparison to
Predicate Device(s): | available in similar diameters and lengths, has a similar
design, and the same indications for use as the predicate
devices and other currently marketed PTA Catheters. |
|--------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Performance Data: | Bench, biocompatibility, and design control activities
demonstrate the safety and effectiveness of the Fox PTA
Catheter. |
| Conclusion: | The Fox PTA Catheter is substantially equivalent to the
claimed predicate devices and other currently marketed
PTA Catheters. |

2

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized caduceus symbol, which is a staff with two snakes entwined around it. The symbol is enclosed within a circle, and the text "DEPARTMENT OF HEALTH & HUMAN SERVICES-USA" is written around the upper portion of the circle. The logo is black and white.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

APR 1 1 2002

Mr. Glenn N. Byrd, MBA, RAC Director, Regulatory Affairs Eminent Research Systems, Inc 1700 Rockville Pike, Suite 400 Rockville, MD 20852

Re: K020854

JoMed Fox PTA Catheter Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous catheter Regulatory Class: Class II (two) Product Code: 74 LIT Dated: April 2, 2002 Received: April 2, 2002

Dear Mr. Byrd:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that vour device complies with other requirements of the Act

3

Page 2 - Mr. Glenn N. Byrd, MBA, RAC

or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4586. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely vours.

AedacMoyn

for

Donna-Bea Tillman, Ph.D. Acting Director Division of Cardiovascular and Respiratory Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

4

510(k) Number (if known):j020854
------------------------------------

Device Name:

Fox PTA Catheter

Indications for Use:

The Fox PTA Catheter is intended for dilatation of lesions in the femoral, renal, iliac, popliteal, peroneal, and profunda arteries and native or synthetic arteriovenous dialysis fistulae.

(PLEASE DO NOT WRITE BELOW THIS LINE – CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH; Office of Device Evaluation (ODE)
Division Sign-Off for Donna. Bee Tillman
Division of Cardiovascular, Respiratory, and Neurological Devices

510(k) NumberK020554
------------------------
Prescription Use (Per 21 CFR 801.109)OROver-The-Counter Use
----------------------------------------------------------------------------

(Optional Format 1-2-96)